A detailed history of Greenwood Capital Associates LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 1,926 shares of MRK stock, worth $199,899. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,926
Previous 14,231 86.47%
Holding current value
$199,899
Previous $1.76 Million 87.62%
% of portfolio
0.03%
Previous 0.24%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$111.15 - $128.97 $1.37 Million - $1.59 Million
-12,305 Reduced 86.47%
1,926 $218,000
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $73,042 - $78,446
-590 Reduced 3.98%
14,231 $1.76 Million
Q1 2024

May 01, 2024

SELL
$113.24 - $131.95 $93,196 - $108,594
-823 Reduced 5.26%
14,821 $1.96 Million
Q4 2023

Mar 05, 2024

BUY
$100.18 - $109.02 $182,628 - $198,743
1,823 Added 13.19%
15,644 $1.71 Million
Q3 2023

Oct 18, 2023

BUY
$102.95 - $114.33 $11,324 - $12,576
110 Added 0.8%
13,821 $1.42 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $64,840 - $70,672
-597 Reduced 4.17%
13,711 $1.58 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $44,675 - $49,849
-434 Reduced 2.94%
14,308 $1.52 Million
Q4 2022

Jan 26, 2023

BUY
$87.44 - $112.11 $28,155 - $36,099
322 Added 2.23%
14,742 $0
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $39,729 - $44,631
470 Added 3.37%
14,420 $1.24 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $1.06 Million - $1.2 Million
12,668 Added 988.14%
13,950 $1.27 Million
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $727,381 - $815,348
-9,895 Reduced 88.53%
1,282 $105,000
Q4 2021

Feb 03, 2022

BUY
$72.28 - $90.54 $130,393 - $163,334
1,804 Added 19.25%
11,177 $856,000
Q3 2021

Oct 27, 2021

BUY
$71.68 - $78.83 $671,856 - $738,873
9,373 New
9,373 $704,000
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $4.21 Million - $4.96 Million
-61,200 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $64,808 - $71,923
903 Added 1.5%
61,200 $5.01 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $365,680 - $414,501
4,997 Added 9.04%
60,297 $5 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $95,137 - $108,255
1,351 Added 2.5%
55,300 $4.28 Million
Q1 2020

May 12, 2020

SELL
$63.36 - $87.82 $1.15 Million - $1.59 Million
-18,073 Reduced 25.09%
53,949 $4.15 Million
Q4 2019

Feb 12, 2020

SELL
$77.58 - $87.54 $52,676 - $59,439
-679 Reduced 0.93%
72,022 $6.25 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $413,799 - $451,056
5,439 Added 8.09%
72,701 $6.12 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $89,394 - $97,442
-1,175 Reduced 1.72%
67,262 $5.64 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $4.78 Million - $5.58 Million
68,437 New
68,437 $5.74 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $263B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.